Radiological peer review of interval cancers in the East Anglian breast screening programme: What are we missing?

Journal of Medical Screening

Volumn 8, Issue 2, 2001, Pages 77-85

  McCann, J ^a   Britton, P D ^b   Warren, R M L ^b   Hunnam, G ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Histological type; Interval cancer; Mammography; Prognosis; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PEER REVIEW; PROGNOSIS;

AGED; BREAST NEOPLASMS; ENGLAND; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PEER REVIEW; RISK FACTORS;

EID: 0034927893     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.8.2.77     Document Type: Article

References (54)

1. The current detectability of breast cancer in a mammographic screening programme
2. Screening
3. Mammographic film density and detection of small breast cancers
4. Breast cancer missed by mammography
5. Monitoring interval cancers in breast screening programmes: The East Anglian experience
6. Is the three year breast screening interval too long? Occurrence of interval cancers in the NHS breast screening programme's north western region
7. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two county breast cancer screening trial
8. Update of the Swedish two-county program of mammographic screening for breast cancer
9. Efficacy of breast cancer screening by age
10. Predicted long term mortality reduction associated with the second round of breast screening in East Anglia
11. Interval cancers in the screening mammography programme of British Columbia
12. The role of the reference radiologist: Estimates of inter-observer agreement and potential delay in cancer detection in the national breast screening study
13. Incident round cancers: What lessons can we learn?
14. Characteristics of breast carcinomas missed by screening
15. Interval cancer peer review in East Anglia: Implications for monitoring doctors as well as the NHS breast screening programme
16. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long follow up
17. The importance of histologic type on breast cancer survival
18. The natural history of breast carcinoma. What have we learned from screening?
19. The Scottish breast screening programme's experience of monitoring interval cancers
20. Interval cancers in the Malmo mammographic screening trial: Radiographic appearance and prognostic implications
21. An analysis of the characteristics of the interval cancers in the Florence district programme 1989-91
22. A comparative audit of prevalent, incidence and interval cancer in the Avon breast screening programme
23. Invasive interval cancers in the Ostergotland mammographic screening programme: Radiological analysis
24. The visibility of cancer on earlier mammograms in a population based screening programme
25. Error in radiology: Classification and lessons in 182 cases presented at a problem case conference
26. Classifying interval cancers
27. Two models for the radiological review of interval cancers
28. Effect of age and breast density on screening mammograms with false positive findings
29. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old
30. Breast cancer in East Anglia: The impact of the breast screening programme on stage at diagnosis
31. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: Earlier diagnosis or better treatment?
32. Histopathology and growth rate of interval breast carcinoma
33. Survival in breast cancer diagnosed between mammographic screening examinations
34. Survival rates from interval cancer in the breast screening programme
35. A study of interval breast cancer within the NHS breast screening programme
36. Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial
37. Mammography screening does not significantly reduce breast cancer mortality in Swedish daily practice
38. Is screening for breast cancer with mammography justifiable?
39. Screening interval breast cancers: Mammographic features and prognostic factors
40. NHS breast screening programme: Is the high incidence of interval cancers inevitable?
41. Aggressiveness of screen detected breast cancers
42. Clinical outcomes of doubtful mammographic findings
43. Do non-specific minimal signs in a biennial breast cancer screening programme need further diagnostic assessment?
44. Previous mammograms in patients with impalpable breast carcinoma: Retrospective versus blinded interpretation
45. Second round cancers: How many were visible on the first round of the UK national breast screening programme, 3 years earlier?
46. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14mm invasive breast cancers: A prospective study
47. What should be done about interval breast cancers?